Verve Therapeutics Inc.

NASDAQ: VERV · Real-Time Price · USD
11.13
0.03 (0.27%)
At close: Jul 24, 2025, 3:59 PM

Verve Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.4 -4.47 -6.64 -15.08
PEG Ratio
0.10 -0.62 -0.35 -0.09
PS Ratio
14.78 76.08 538.57 n/a
PB Ratio
0.97 1.49 1.90 5.01
P/FCF Ratio
-2.96 -5.63 -7.71 -21.75
P/OCF Ratio
-3.03 -5.98 -8.55 -22.97
OCF/S Ratio
-4.88 -12.72 -63.03 n/a
Debt / Equity Ratio
0.14 0.12 0.15 0.01
Quick Ratio
12.65 17.24 16.05 16.67
Current Ratio
12.65 17.24 16.05 16.67
Asset Turnover
0.05 0.02 0.00 n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.4 -0.33 -0.29 -0.33
Return on Assets
-0.31 -0.27 -0.23 -0.31
Return on Invested Capital
-0.37 -0.31 -0.25 -0.23
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00 n/a
Net Profit Margin
-6.15 -17.02 -81.09 n/a
Pretax Profit Margin
-6.14 -16.99 -81.06 n/a
Operating Profit Margin
-7.07 -18.98 -85.36 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-6.86 -18.51 -83.92 n/a